NCT05213208

Safety of Propofol Sedation ( > 200 mg) for Colonoscopy.

Propofol Sedation of More Than 200 mg Enables Patients to Drive Home After Outpatient Colonoscopy Including Colorectal Polypectomy

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 300 (actual)
• Sponsor: Showa Inan General Hospital · Academic / Other
• Sex: All
• Age: 20 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

This study examines that the use of \>200 mg of propofol sedation enables patients to drive home safely after outpatient colonoscopy.

Detailed description

The hospital policy of routine discharge to normal activity 1 hour after propofol mono-sedation for EGD or colonoscopy was approved by the ethics committee of Showa Inan General Hospital in January, 2004 (http://www.sihp.jp). The investigator' s subsequent experience verified the safety of this discharge policy which was reconfirmed in March 2014. Based on these studies, the upper limit of 200 mg was established for those allowed early discharge and driving to home. This study examines that the use of \>200 mg of propofol sedation enables patients to drive home safely 90-120 minutes after outpatient colonoscopy.

Conditions

• Safety Issues

Interventions

Type	Name	Description
DRUG	Propofol	Using \> 200 mg of propofol sedation colonoscopy is performed. 90-120 minutes after colonoscopy subjects go home. Within 1 week patients will be asked about their condition and satisfaction for colonoscopy.

Timeline

• Start date: 2022-01-16
• Primary completion: 2024-12-31
• Completion: 2024-12-31
• First posted: 2022-01-28
• Last updated: 2025-05-18

Locations

1 site across 1 country: Japan